| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Olema Pharmaceuticals, Inc. (OLMA) has 10 insiders with recent SEC Form 4 filings, including 5 buys and 2 sells. OLMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 737.8K | $7.38M | - | |
| CEO | 275.0K | $2.75M | - | |
| Other | 250.0K | $2.50M | - | |
| Dir | 209.7K | $2.10M | - | |
| Other | 139.7K | $1.40M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2021 | Horn Kinney87 | Chief Business Officer | Sale+OE | 57,763 | $24.15 | $1,394,769.27 | -82.6% | +6.8% | -91.4% | |
| Nov 23, 2020 | Graham G. Walmsley48 | Director | Buy | 1,160,000 | $19.00 | $22,040,000.00 | New | - | - | |
| Nov 23, 2020 | Cormorant Asset Management, LP49 | Former 10% Owner | Buy | 425,000 | $19.00 | $8,075,000.00 | +14.9% | - | - | |
| Nov 19, 2020 | Bvf Partners L P/il59 | Director, 10% Owner | Buy | 1,135,334 | $19.00 | $21,571,346.00 | +21.8% | - | - |